RT Journal Article
SR Electronic
T1 Individual differences in the course of youth depression: The importance of renitence and reversion
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19012872
DO 10.1101/19012872
A1 Hawrilenko, Matt
A1 Masyn, Katherine E.
A1 Cerutti, Janine
A1 Dunn, Erin C.
YR 2019
UL http://medrxiv.org/content/early/2019/11/27/19012872.abstract
AB Studies of developmental trajectories of depression are important for understanding its etiology. Existing studies have been limited by short time frames and no studies have explored a key factor: differential patterns of responding to life events. This paper introduces a novel analytic technique, growth mixture modeling with structured residuals, to examine the course of youth depression symptoms in a large, prospective cohort (N=11,641, ages 4-16.5). Age-specific critical points were identified at ages 10 and 13 where depression symptoms spiked for a minority of children. However, most depression risk was due to dynamic responses to environmental events, drawn not from a small pool of persistently depressed children, but a larger pool of children who varied across higher and lower symptom levels.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the National Institute of Mental Health of the National Institutes of Health under Award Numbers K01MH102403 and 1R01MH113930 (Dunn). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The UK Medical Research Council and the Welcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData came from Avon Longitudinal Study of Parents and Children (ALSPAC). To explore data and samples, the study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool: www.bristol.ac.uk/alspac/researchers/our-data/. To request existing data, ALSPAC encourages researchers to: 1. Please read the ALSPAC access policy, which describes the process of accessing the data and samples in detail, and outlines the costs associated with doing so. 2. You may also find it useful to browse ALSPAC's fully searchable research proposals database, which lists all research projects that have been approved since April 2011. 3. Please submit your research proposal for consideration by the ALSPAC Executive Committee. You will receive a response within 10 working days to advise you whether your proposal has been approved. http://www.bristol.ac.uk/media-library/sites/alspac/documents/researchers/data-access/ALSPAC_Access_Policy.pdf https://proposals.epi.bristol.ac.uk/?_ga=2.149616694.1895310552.1574350382-1596101750.1574350382 https://proposals.epi.bristol.ac.uk/?_ga=2.149616694.1895310552.1574350382-1596101750.1574350382